Enovis Corporation/$ENOV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Ticker
$ENOV
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
7,367
ISIN
US1940145022
Website
ENOV Metrics
BasicAdvanced
$1.8B
-
-$14.50
1.90
-
Price and volume
Market cap
$1.8B
Beta
1.9
52-week high
$49.38
52-week low
$29.32
Average daily volume
1M
Financial strength
Current ratio
2.552
Quick ratio
0.993
Long term debt to equity
54.068
Total debt to equity
54.832
Interest coverage (TTM)
0.96%
Management effectiveness
Return on assets (TTM)
0.92%
Return on equity (TTM)
-27.35%
Valuation
Price to revenue (TTM)
0.832
Price to book
0.7
Price to tangible book (TTM)
-3.98
Price to free cash flow (TTM)
-45.881
Growth
Revenue change (TTM)
18.32%
Earnings per share change (TTM)
860.33%
3-year revenue growth (CAGR)
12.99%
3-year earnings per share growth (CAGR)
124.79%
ENOV News
AllArticlesVideos
Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor
GlobeNewsWire·4 days ago
Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript
Seeking Alpha·3 weeks ago
Enovis Announces First Quarter 2025 Results
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Enovis Corporation stock?
Enovis Corporation (ENOV) has a market cap of $1.8B as of May 30, 2025.
What is the P/E ratio for Enovis Corporation stock?
The price to earnings (P/E) ratio for Enovis Corporation (ENOV) stock is 0 as of May 30, 2025.
Does Enovis Corporation stock pay dividends?
No, Enovis Corporation (ENOV) stock does not pay dividends to its shareholders as of May 30, 2025.
When is the next Enovis Corporation dividend payment date?
Enovis Corporation (ENOV) stock does not pay dividends to its shareholders.
What is the beta indicator for Enovis Corporation?
Enovis Corporation (ENOV) has a beta rating of 1.9. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.